Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 10:39 PM
Study NCT ID:
NCT00784667
Status:
UNKNOWN
Last Update Posted:
2010-11-30
First Post:
2008-11-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib
Sponsor:
Austin Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-10
Start Date Type:
None
Primary Completion Date:
2010-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-02
Completion Date Type:
ESTIMATED
First Submit Date:
2008-11-03
First Submit QC Date:
None
Study First Post Date:
2008-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-11-29
Last Update Post Date:
2010-11-30
Last Update Post Date Type:
ESTIMATED